Latest Press

Cristcot Announces Positive Phase 3 Results for Novel Hydrocortisone Acetate Suppository Administered with the Sephure® Suppository Applicator for the Treatment of Ulcerative Colitis of the Rectum

Read

Royalty Pharma Announces Transformative Step in Company’s Evolution with Acquisition of its External Manager and $3 Billion Share Repurchase Program

Read

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

Read

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

Read

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Read

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Read

Royalty Pharma

Transforming the funding of life sciences through collaborative capital, Royalty Pharma developed and is the leader in the pharmaceutical royalty business.

Royalty Pharma

RP

ADC Therapeutics

ADC Therapeutics is focused on the development of proprietary Antibody Drug Conjugates for the treatment of both solid and hematological cancers.

ADC Therapeutics

ADCT

Intra-Cellular Therapies

Intra-Cellular Therapies is a leading biopharmaceutical company founded by Nobel Prize winner: Paul Greengard...

Intra-Cellular Therapies

Scientia Ventures

Scientia

About

Portfolio

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Portfolio

About

People

Podcasts

News

Portfolio

People

Podcasts

News

About

Scientia Ventures

knowledge is power

In short

Intelligent Investment in Healthcare

In Numbers

31

5

Latest Press

Cristcot Announces Positive Phase 3 Results for Novel Hydrocortisone Acetate Suppository Administered with the Sephure® Suppository Applicator for the Treatment of Ulcerative Colitis of the Rectum

Royalty Pharma Announces Transformative Step in Company’s Evolution with Acquisition of its External Manager and $3 Billion Share Repurchase Program

Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

Highlights

Royalty Pharma

RP

ADC Therapeutics

ADCT

Intra-Cellular Therapies

ICT

Intelligent Investment in Healthcare

SIGnUP

Scientia Ventures™

Intelligent Investment
in Healthcare

SIGn
UP